プロフィール詳細

プロジェクトを作成

★★★★★

☆☆☆☆☆

★★★★★

☆☆☆☆☆

Vanesa H.に依頼

United Kingdom

HTA Research Analyst

プロフィール概要

I have four years experience in Health Technology Assessments (HTA) submissions as part of an Evidence Review Group. I have covered positioning in the clinical pathway and clinical effectiveness. I am highly experienced at Risk of Bias Assessment for Systematic Reviews (n>300). I have also conducted statistical peer reviews for an international medical journal (n>80). In addition to the above I can also carry out systematic literature review screening and data extraction. Highly committed and fully reliable. I am a registered practising Pharmacist and I'm trained in Public Health and Applied Health Research at the University of York.

専門分野

• ★ Research Methodology
• ☆ Health Economics

サービス

• Writing
• Research
• Consulting
• Data & AI

Writing Clinical Trial Documentation, Technical Writing

Research Market Research

Consulting Scientific and Technical Consulting

Data & AI Statistical Analysis

職務経験

Research Associate

Kleijnen Systematic Reviews Ltd

11月 2016 - 9月 2020

学歴

Masters in Public Health

University of York

9月 2015 - 9月 2016

認定資格

• 認定資格の詳細は未入力です。

出版物

JOURNAL ARTICLE

Witlox, Willem JA and Grimm, Sabine E and Riemsma, Rob and Armstrong, Nigel and Ryder, Steve and Duffy, Steven and Carrera, Vanesa Huertas and Posadzki, Pawel and Worthy, Gillian and Pouwels, Xavier GLV and others(2021). Lenalidomide with rituximab for previously treated follicular lymphoma and marginal zone lymphoma: an evidence review group perspective of a NICE single technology appraisal. PharmacoEconomics. 39. (2). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 171--180. Springer

Witlox, Willem JA and Grimm, Sabine E and Riemsma, Rob and Armstrong, Nigel and Ryder, Steve and Duffy, Steven and Carrera, Vanesa Huertas and Posadzki, Pawel and Worthy, Gillian and Pouwels, Xavier GLV and others(2021). Lenalidomide with rituximab for previously treated follicular lymphoma and marginal zone lymphoma: an evidence review group perspective of a NICE single technology appraisal. PharmacoEconomics. 39. (2). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 171--180. Springer

Armstrong, Nigel and B{\"u}y{\"u}kkaramikli, Nasuh and Penton, Hannah and Riemsma, Rob and Wetzelaer, Pim and Carrera, Vanesa Huertas and Swift, Stephanie and Drachen, Thea and Raatz, Heike and Ryder, Steve and others(2020). Avatrombopag and lusutrombopag for thrombocytopenia in people with chronic liver disease needing an elective procedure: a systematic review and cost-effectiveness analysis. Health Technology Assessment (Winchester, England). 24. (51). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 1. Various

Buksnys, Titas and Armstrong, Nigel and Worthy, Gill and Sabatschus, Ingo and Boesl, Irmgard and Buchheister, Bettina and Swift, Stephanie L and Noake, Caro and Huertas Carrera, Vanessa and Ryder, Steve and others(2020). Systematic review and network meta-analysis of the efficacy and safety of lidocaine 700 mg medicated plaster vs. pregabalin. Current medical research and opinion. 36. (1). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 101--115. Taylor \& Francis

Pouwels, Xavier GLV and Petersohn, Svenja and Carrera, Vanesa Huertas and Denniston, Alastair K and Chalker, Annette and Raatz, Heike and Armstrong, Nigel and Shah, Dhwani and Witlox, Willem and Worthy, Gill and others(2020). Fluocinolone acetonide intravitreal implant for treating recurrent non-infectious uveitis: an evidence review group perspective of a NICE single technology appraisal. PharmacoEconomics. 38. (5). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 431--441. Springer

Frederick W. Thielen and Nasuh C. Büyükkaramikli and Rob Riemsma and Debra Fayter and Nigel Armstrong and Ching-Yun Wei and Vanesa Huertas Carrera and Kate Misso and Gill Worthy and Jos Kleijnen and Isaac Corro Ramos(2019). Obinutuzumab in Combination with Chemotherapy for the First-Line Treatment of Patients with Advanced Follicular Lymphoma . PharmacoEconomics. 37. (8). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 975--984. Springer Science and Business Media {LLC}

Ryder, Steve and Buksnys, Titas and Armstrong, Nigel and Worthy, Gill and Boesl, Irmgard and Swift, S and Noake, Caro and Liedgens, Hiltrud and Carrera, V Huertas and Kleijnen, Jos(2019). PMU6 SYSTEMATIC REVIEW OF THE EFFICACY AND SAFETY OF 5% LIDOCAINE-MEDICATED PLASTER VS. PREGABALIN. Value in Health. 22. Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString S708. Elsevier

Carrera, Vanesa Huertas and Worthy, Gill and Kleijnen, Joseph(2019). PP48 Risk Of Bias Of Systematic Reviews Connected To Journal Impact Factor?. International Journal of Technology Assessment in Health Care. 35. (S1). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 46--46. Cambridge University Press